BMP signaling in mesenchymal stem cell differentiation and bone formation — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
BMP signaling in mesenchymal stem cell differentiation and bone formation
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA Stem Cell Biology and Therapy Laboratory of the Key Laboratory for Pediatrics Co-Designated by Chinese Ministry of Education, The Children’s Hospital of Chongqing Medical University, Chongqing, China
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA Stem Cell Biology and Therapy Laboratory of the Key Laboratory for Pediatrics Co-Designated by Chinese Ministry of Education, The Children’s Hospital of Chongqing Medical University, Chongqing, China
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
,
Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA Stem Cell Biology and Therapy Laboratory of the Key Laboratory for Pediatrics Co-Designated by Chinese Ministry of Education, The Children’s Hospital of Chongqing Medical University, Chongqing, China The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
1 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
2 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
3 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA Stem Cell Biology and Therapy Laboratory of the Key Laboratory for Pediatrics Co-Designated by Chinese Ministry of Education, The Children’s Hospital of Chongqing Medical University, Chongqing, China
4 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
5 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA Stem Cell Biology and Therapy Laboratory of the Key Laboratory for Pediatrics Co-Designated by Chinese Ministry of Education, The Children’s Hospital of Chongqing Medical University, Chongqing, China
6 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
7 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
8 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
9 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
10 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
11 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
Bone morphogenetic proteins (BMPs) are members of the TGF- β superfamily and have diverse functions during development and organogenesis. BMPs play a major role in skeletal development and bone formation, and disruptions in BMP signaling cause a variety of skeletal and extraskeletal anomalies. Several knockout models have provided insight into the mechanisms responsible for these phenotypes. Proper bone formation requires the differentiation of osteoblasts from mesenchymal stem cell (MSC) precursors, a process mediated in part by BMP signaling. Multiple BMPs, including BMP2, BMP6, BMP7 and BMP9, promote osteoblastic differentiation of MSCs both in vitro and in vivo . BMP9 is one of the most osteogenic BMPs, yet it is a poorly characterized member of the BMP family. Several studies demonstrate that the mechanisms controlling BMP9-mediated osteogenesis differ from other osteogenic BMPs, but little is known about these specific mechanisms. Several pathways critical to BMP9-mediated osteogenesis are also important in the differentiation of other cell lineages, including adipocytes and chondrocytes. BMP9 has also demonstrated translational promise in spinal fusion and bone fracture repair. This review will summarize our current knowledge of BMP-mediated osteogenesis, with a focus on BMP9, by presenting recently completed work which may help us to further elucidate these pathways.
[1] Attisano, L. and Wrana, J.L. (2002) Signal transduction by the TGF-beta superfamily. Science, 296, 1646-1647. doi:10.1126/science.1071809
Hogan, B.L. (1996) Bone morphogenetic proteins in development. Current Opinion in Genetics & Development, 6, 432-438. doi:10.1016/S0959-437X(96)80064-5
Shi, Y. and Massague, J. (2003) Mechanisms of TGFbeta signaling from cell membrane to the nucleus. Cell, 113, 685-700. doi:10.1016/S0092-8674(03)00432-X
Varga, A.C. and Wrana, J.L. (2005) The disparate role of BMP in stem cell biology. Oncogene, 24, 5713-5721. doi:10.1038/sj.onc.1208919
Zhang, J. and Li, L. (2005) BMP signaling and stem cell regulation. Developmental Biology, 284, 1-11. doi:10.1016/j.ydbio.2005.05.009
Christiansen, J.H., Coles, E.G. and Wilkinson, D.G. (2000) Molecular control of neural crest formation, migration and differentiation. Current Opinion in Cell Biology, 12, 719-724. doi:10.1016/S0955-0674(00)00158-7
Derynck, R. and Feng, X.H. (1997) TGF-beta receptor signaling. Biochimica et Biophysica Acta, 1333, F105-F150.
Di Cesare, P.E., Frenkel, S.R., Carlson, C.S., Fang, C. and Liu, C. (2006) Regional gene therapy for full-thickness articular cartilage lesions using naked DNA with a collagen matrix. Journal of Orthopaedic Research, 24, 1118-1127.
Hu, J., Chen, Y.X., Wang, D., Qi, X., Li, T.G., Hao, J., Mishina, Y., Garbers, D.L. and Zhao, G.Q. (2004) Developmental expression and function of Bmp4 in spermatogenesis and in maintaining epididymal integrity. Developmental Biology, 276, 158-171. doi:10.1016/j.ydbio.2004.08.034
Kuo, A.C., Rodrigo, J.J., Reddi, A.H., Curtiss, S., Grotkopp, E. and Chiu, M. (2006) Microfracture and bone morphogenetic protein 7 (BMP-7) synergistically stimulate articular cartilage repair. Osteoarthritis and Cartilage, 14, 1126-1135. doi:10.1016/j.joca.2006.04.004
Luu, H.H., Song, W.X., Luo, X., Manning, D., Luo, J., Deng, Z.L., Sharff, K.A., Montag, A.G., Haydon, R.C. and He, T.C. (2007) Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. Journal of Orthopaedic Research, 25, 665-677. doi:10.1002/jor.20359
Mitu, G. and Hirschberg, R. (2008) Bone morphogenetic protein-7 (BMP7) in chronic kidney disease. Frontiers in Bioscience, 13, 4726-4739.
Kang, Q., Sun, M.H., Cheng, H., Peng, Y., Montag, A.G., Deyrup, A.T., Jiang, W., Luu, H.H., Luo, J., Szatkowski, J.P., Vanichakarn, P., Park, J.Y., Li, Y., Haydon, R.C. and He, T.C. (2004) Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Therapy, 11, 1312-1320. doi:10.1038/sj.gt.3302298
12 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
13 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
14 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
15 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
16 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
17 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
18 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
19 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
20 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA
21 Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, USA Stem Cell Biology and Therapy Laboratory of the Key Laboratory for Pediatrics Co-Designated by Chinese Ministry of Education, The Children’s Hospital of Chongqing Medical University, Chongqing, China The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
Luther, G., Wagner, E.R., Zhu, G., Kang, Q., Luo, Q., Lamplot, J., Bi, Y., Luo, X., Luo, J., Teven, C., Shi, Q., Kim, S.H., Gao, J.L., Huang, E., Yang, K., Rames, R., Liu, X., Li, M., Hu, N., Liu, H., Su, Y., Chen, L., He, B.C., Zuo, G.W., Deng, Z.L., Reid, R.R., Luu, H.H., Haydon, R.C. and He, T.C. (2011) BMP-9 induced osteogenic differentiation of mesenchymal stem cells: Molecular mechanism and therapeutic potential. Current Gene Therapy, 11, 229-240. doi:10.2174/156652311795684777
Aubin, J.E. (2001) Regulation of osteoblast formation and function. Reviews in Endocrine and Metabolic Disorders, 2, 81-94. doi:10.1023/A:1010011209064
Deng, Z.L., Sharff, K.A., Tang, N., Song, W.X., Luo, J., Luo, X., Chen, J., Bennett, E., Reid, R., Manning, D., Xue, A., Montag, A.G., Luu, H.H., Haydon, R.C. and He, T.C. (2008) Regulation of osteogenic differentiation during skeletal development. Frontiers in Bioscience, 13, 2001-2021. doi:10.2741/2819
He, B.C., Chen, L., Zuo, G.W., Zhang, W., Bi, Y., Huang, J., Wang, Y., Jiang, W., Luo, Q., Shi, Q., Zhang, B.Q., Liu, B., Lei, X., Luo, J., Luo, X., Wagner, E.R., Kim, S.H., He, C.J., Hu, Y., Shen, J., Zhou, Q., Rastegar, F., Deng, Z.L., Luu, H.H., He, T.C. and Haydon, R.C. (2010) Synergistic antitumor effect of the activated PPAR-gamma and retinoid receptors on human osteosarcoma. Clinical Cancer Research, 16, 2235-2245. doi:10.1158/1078-0432.CCR-09-2499
Kang, Q., Song, W.X., Luo, Q., Tang, N., Luo, J., Luo, X., Chen, J., Bi, Y., He, B.C., Park, J.K., Jiang, W., Tang, Y., Huang, J., Su, Y., Zhu, G.H., He, Y., Yin, H., Hu, Z., Wang, Y., Chen, L., Zuo, G.W., Pan, X., Shen, J., Vokes, T., Reid, R.R., Haydon, R.C., Luu, H.H. and He, T.C. (2009) A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differenttiation of mesenchymal progenitor cells. Stem Cells and Development, 18, 545-559. doi:10.1089/scd.2008.0130
Wozney, J.M., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., Hewick, R.M. and Wang, E.A. (1988) Novel regulators of bone formation: Molecular clones and activities. Science, 242, 1528-1534. doi:10.1126/science.3201241
Hogan, B.L. (1996) Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes & Development, 10, 1580-1594. doi:10.1101/gad.10.13.1580
Zhao, G.Q. (2003) Consequences of knocking out BMP signaling in the mouse. Genesis, 35, 43-56. doi:10.1002/gene.10167
Song, J.J., Celeste, A.J., Kong, F.M., Jirtle, R.L., Rosen, V. and Thies, R.S. (1995) Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology, 136, 4293-4297. doi:10.1210/en.136.10.4293
Chen, C., Grzegorzewski, K.J., Barash, S., Zhao, Q., Schneider, H., Wang, Q., Singh, M., Pukac, L., Bell, A.C., Duan, R., Coleman, T., Duttaroy, A., Cheng, S., Hirsch, J., Zhang, L., Lazard, Y., Fischer, C., Barber, M.C., Ma, Z.D., Zhang, Y.Q., Reavey, P., Zhong, L., Teng, B., Sanyal, I., Ruben, S.M., Blondel, O. and Birse, C.E. (2003) An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis. Nature Biotechnology, 21, 294-301.
Lopez-Coviella, I., Berse, B., Krauss, R., Thies, R.S. and Blusztajn, J.K. (2000) Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. Science, 289, 313-316. doi:10.1126/science.289.5477.313
Truksa, J., Peng, H., Lee, P. and Beutler, E. (2006) Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proceedings of the National Academy of Sciences of the United States of America, 103, 10289-10293. doi:10.1073/pnas.0603124103
Cheng, H., Jiang, W., Phillips, F.M., Haydon, R.C., Peng, Y., Zhou, L., Luu, H.H., An, N., Breyer, B., Vanichakarn, P., Szatkowski, J.P., Park, J.Y. and He, T.C. (2003) Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). The Journal of Bone and Joint Surgery. American Volume, 85-A, 1544-1552.
Luo, Q., Kang, Q., Si, W., Jiang, W., Park, J.K., Peng, Y., Li, X., Luu, H.H., Luo, J., Montag, A.G., Haydon, R.C. and He, T.C. (2004) Connective tissue growth factor (CTGF) is regulated by wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. The Journal of Biological Chemistry, 279, 55958-55968. doi:10.1074/jbc.M407810200
Peng, Y., Kang, Q., Cheng, H., Li, X., Sun, M.H., Jiang, W., Luu, H.H., Park, J.Y., Haydon, R.C. and He, T.C. (2003) Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. Journal of Cellular Biochemistry, 90, 1149-1165. doi:10.1002/jcb.10744
Peng, Y., Kang, Q., Luo, Q., Jiang, W., Si, W., Liu, B.A., Luu, H.H., Park, J.K., Li, X., Luo, J., Montag, A.G., Haydon, R.C. and He, T.C. (2004) Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. The Journal of Biological Chemistry, 279, 32941-32949. doi:10.1074/jbc.M403344200
Karsenty, G. (1999) The genetic transformation of bone biology. Genes & Development, 13, 3037-3051. doi:10.1101/gad.13.23.3037
Lian, J.B., Stein, G.S., Stein, J.L. and van Wijnen, A.J. (1998) Transcriptional control of osteoblast differentiation. Biochemical Society Transactions, 26, 14-21.
Reddi, A.H. (1997) Bone morphogenetic proteins: An unconventional approach to isolation of first mammalian morphogens. Cytokine & Growth Factor Reviews, 8, 11-20. doi:10.1016/S1359-6101(96)00049-4
Lin, G.L. and Hankenson, K.D. (2011) Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. Journal of Cellular Biochemistry, 112, 3491-3501. doi:10.1002/jcb.23287
Marcellini, S., Henriquez, J.P. and Bertin, A. (2012) Control of osteogenesis by the canonical Wnt and BMP pathways in vivo: Cooperation and antagonism between the canonical Wnt and BMP pathways as cells differentiate from osteochondroprogenitors to osteoblasts and osteocytes. Bioessays, 34, 953-962. doi:10.1002/bies.201200061
Olsen, B.R., Reginato, A.M. and Wang, W. (2000) Bone development. Annual Review of Cell and Developmental Biology, 16, 191-220. doi:10.1146/annurev.cellbio.16.1.191
Ducy, P. and Karsenty, G. (2000) The family of bone morphogenetic proteins. Kidney International, 57, 2207-2214. doi:10.1046/j.1523-1755.2000.00081.x
Ducy, P., Starbuck, M., Priemel, M., Shen, J., Pinero, G., Geoffroy, V., Amling, M. and Karsenty, G. (1999) A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes & Development, 13, 1025-1036. doi:10.1101/gad.13.8.1025
Reddi, A.H. (1998) Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nature Biotechnology, 16, 247-252.
Harada, S. and Rodan, G.A. (2003) Control of osteoblast function and regulation of bone mass. Nature, 423, 349-355.
Ralston, S.H. and de Crombrugghe, B. (2006) Genetic regulation of bone mass and susceptibility to osteoporosis. Genes & Development, 20, 2492-2506. doi:10.1101/gad.1449506
King, J.A., Marker, P.C., Seung, K.J. and Kingsley, D.M. (1994) BMP5 and the molecular, skeletal, and soft-tissue alterations in short ear mice. Developmental Biology, 166, 112-122. doi:10.1006/dbio.1994.1300
Hall, P.A. and Watt, F.M. (1989) Stem cells: The generation and maintenance of cellular diversity. Development, 106, 619-633.
Tsumaki, N. and Yoshikawa, H. (2005) The role of bone morphogenetic proteins in endochondral bone formation. Cytokine & Growth Factor Reviews, 16, 279-285. doi:10.1016/j.cytogfr.2005.04.001
Wu, N., Zhao, Y., Yin, Y., Zhang, Y. and Luo, J. (2010) Identification and analysis of type II TGF-beta recaptors in BMP-9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. Acta Biochimica et Biophysica Sinica, 42, 699-708. doi:10.1093/abbs/gmq075
Wu, X., Shi, W. and Cao, X. (2007) Multiplicity of BMP signaling in skeletal development. Annals of the New York Academy of Sciences, 1116, 29-49. doi:10.1196/annals.1402.053
Shu, B., Zhang, M., Xie, R., Wang, M., Jin, H., Hou, W., Tang, D., Harris, S.E., Mishina, Y., O’Keefe, R.J., Hilton, M.J., Wang, Y. and Chen, D. (2011) BMP2, but not BMP4, is crucial for chondrocyte proliferation and maturation during endochondral bone development. Journal of Cell Science, 124, 3428-3440. doi:10.1242/jcs.083659
Estrada, K.D., Retting, K.N., Chin, A.M. and Lyons, K.M. (2011) Smad6 is essential to limit BMP signaling during cartilage development. Journal of Bone and Mineral Research, 26, 2498-2510.
Pan, Q., Yu, Y., Chen, Q., Li, C., Wu, H., Wan, Y., Ma, J. and Sun, F. (2008) Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter. Journal of Cellular Physiology, 217, 228-241. doi:10.1002/jcp.21496
Zehentner, B.K., Dony, C. and Burtscher, H. (1999) The transcription factor Sox9 is involved in BMP-2 signaling. Journal of Bone and Mineral Research, 14, 1734-1741. doi:10.1359/jbmr.1999.14.10.1734
Wang, M., Jin, H., Tang, D., Huang, S., Zuscik, M.J. and Chen, D. (2011) Smad1 plays an essential role in bone development and postnatal bone formation. Osteoarthritis and Cartilage, 19, 751-762. doi:10.1016/j.joca.2011.03.004
Yoon, B.S. and Lyons, K.M. (2004) Multiple functions of BMPs in chondrogenesis. Journal of Cellular Biochemistry, 93, 93-103. doi:10.1002/jcb.20211
Canalis, E., Brunet, L.J., Parker, K. and Zanotti, S. (2012) Conditional inactivation of noggin in the postnatal skeleton causes osteopenia. Endocrinology, 153, 1616-1626. doi:10.1210/en.2011-1604
Smith, W.C. and Harland, R.M. (1992) Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell, 70, 829-840. doi:10.1016/0092-8674(92)90316-5
Valenzuela, D.M., Economides, A.N., Rojas, E., Lamb, T.M., Nunez, L., Jones, P., Lp, N.Y., Espinosa 3rd, R., Brannan, C.I., Gilbert, D.J., et al. (1995) Identification of mammalian noggin and its expression in the adult nervous system. The Journal of Neuroscience, 15, 6077-6084.
Zimmerman, L.B., De Jesus-Escobar, J.M. and Harland, R.M. (1996) The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell, 86, 599-606. doi:10.1016/S0092-8674(00)80133-6
Devlin, R.D., Du, Z., Pereira, R.C., Kimble, R.B., Economides, A.N., Jorgetti, V. and Canalis, E. (2003) Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology, 144, 1972-1978. doi:10.1210/en.2002-220918
Brunet, L.J., McMahon, J.A., McMahon, A.P. and Harland, R.M. (1998) Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science, 280, 1455-1457. doi:10.1126/science.280.5368.1455
Kamiya, N., Kobayashi, T., Mochida, Y., Yu, P.B., Yamauchi, M., Kronenberg, H.M. and Mishina, Y. (2009) Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. Journal of Bone and Mineral Research, 25, 200-210. doi:10.1359/jbmr.090806
Kamiya, N., Ye, L., Kobayashi, T., Lucas, D.J., Mochida, Y., Yamauchi, M., Kronenberg, H.M., Feng, J.Q. and Mishina, Y. (2008) Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass. Journal of Bone and Mineral Research, 23, 2007-2017. doi:10.1359/jbmr.080809
Kamiya, N., Ye, L., Kobayashi, T., Mochida, Y., Yamauchi, M., Kronenberg, H.M., Feng, J.Q. and Mishina, Y. (2008) BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development, 135, 3801-3811. doi:10.1242/dev.025825
Zhao, M., Harris, S.E., Horn, D., Geng, Z., Nishimura, R., Mundy, G.R. and Chen, D. (2002) Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation. Journal of Cellular Biochemistry, 157, 1049-1060. doi:10.1083/jcb.200109012
Francis-West, P.H., Tatla, T. and Brickell, P.M. (1994) Expression patterns of the bone morphogenetic protein genes Bmp-4 and Bmp-2 in the developing chick face suggest a role in outgrowth of the primordia. Developmental Dynamics, 201, 168-178. doi:10.1002/aja.1002010207
Wan, C., Shao, J., Gilbert, S.R., Riddle, R.C., Long, F., Johnson, R.S., Schipani, E. and Clemens, T.L. (2010) Role of HIF-1alpha in skeletal development. Annals of the New York Academy of Sciences, 1192, 322-326. doi:10.1111/j.1749-6632.2009.05238.x
Kanzler, B., Foreman, R.K., Labosky, P.A. and Mallo, M. (2000) BMP signaling is essential for development of skeletogenic and neurogenic cranial neural crest. Development, 127, 1095-1104.
Luo, J., Tang, M., Huang, J., He, B.C., Gao, J.L., Chen, L., Zuo, G.W., Zhang, W., Luo, Q., Shi, Q., Zhang, B.Q., Bi, Y., Luo, X., Jiang, W., Su, Y., Shen, J., Kim, S.H., Huang, E., Gao, Y., Zhou, J.Z., Yang, K., Luu, H.H., Pan, X., Haydon, R.C., Deng, Z.L. and He, T.C. (2010) TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. The Journal of Biological Chemistry, 285, 29588-29598. doi:10.1074/jbc.M110.130518
Dudas, M., Sridurongrit, S., Nagy, A., Okazaki, K. and Kaartinen, V. (2004) Craniofacial defects in mice lacking BMP type I receptor Alk2 in neural crest cells. Mechanisms of Development, 121, 173-182. doi:10.1016/j.mod.2003.12.003
Bandyopadhyay, A., Tsuji, K., Cox, K., Harfe, B.D., Rosen, V. and Tabin, C.J. (2006) Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genetics, 2, e216. doi:10.1371/journal.pgen.0020216
Dudley, A.T., Lyons, K.M. and Robertson, E.J. (1995) A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes & Development, 9, 2795-2807. doi:10.1101/gad.9.22.2795
Luo, G., Hofmann, C., Bronckers, A.L., Sohocki, M., Bradley, A. and Karsenty, G. (1995) BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes & Development, 9, 2808-2820. doi:10.1101/gad.9.22.2808
McPherron, A.C., Lawler, A.M. and Lee, S.J. (1999) Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nature Genetics, 22, 260-264. doi:10.1038/10320
Daluiski, A., Engstrand, T., Bahamonde, M.E., Gamer, L.W., Agius, E., Stevenson, S.L., Cox, K., Rosen, V. and Lyons, K.M. (2001) Bone morphogenetic protein-3 is a negative regulator of bone density. Nature Genetics, 27, 84-88. doi:10.1038/83810
Winnier, G., Blessing, M., Labosky, P.A. and Hogan, B.L. (1995) Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes & Development, 9, 2105-2116. doi:10.1101/gad.9.17.2105
Alden, T.D., Pittman, D.D., Beres, E.J., Hankins, G.R., Kallmes, D.F., Wisotsky, B.M., Kerns, K.M. and Helm, G.A. (1999) Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. Journal of Neurosurgery, 90, 109-114.
Alden, T.D., Pittman, D.D., Hankins, G.R., Beres, E.J., Engh, J.A., Das, S., Hudson, S.B., Kerns, K.M., Kallmes, D.F. and Helm, G.A. (1999) In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Human Gene Therapy, 10, 2245-2253. doi:10.1089/10430349950017220
Baltzer, A.W., Lattermann, C., Whalen, J.D., Ghivizzani, S., Wooley, P., Krauspe, R., Robbins, P.D. and Evans, C.H. (2000) Potential role of direct adenoviral gene transfer in enhancing fracture repair. Clinical Orthopaedics and Related Research, S120-S125.
Baltzer, A.W., Lattermann, C., Whalen, J.D., Wooley, P., Weiss, K., Grimm, M., Ghivizzani, S.C., Robbins, P.D. and Evans, C.H. (2000) Genetic enhancement of fracture repair: Healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Therapy, 7, 734-739. doi:10.1038/sj.gt.3301166
Bosch, P., Musgrave, D., Ghivizzani, S., Latterman, C., Day, C.S. and Huard, J. (2000) The efficiency of musclederived cell-mediated bone formation. Cell Transplant, 9, 463-470.
Breitbart, A.S., Grande, D.A., Mason, J.M., Barcia, M., James, T. and Grant, R.T. (1999) Gene-enhanced tissue engineering: Applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene. Annals of Plastic Surgery, 42, 488-495. doi:10.1097/00000637-199905000-00005
Franceschi, R.T., Wang, D., Krebsbach, P.H. and Rutherford, R.B. (2000) Gene therapy for bone formation: In vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. Journal of Cellular Biochemistry, 78, 476-486. doi:10.1002/1097-4644(20000901)78:3 3.0.CO;2-5
Gazit, D., Turgeman, G., Kelley, P., Wang, E., Jalenak, M., Zilberman, Y. and Moutsatsos, I. (1990) Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: A novel cell-mediated gene therapy. The Journal of Gene Medicine, 1, 121-133. doi:10.1002/(SICI)1521-2254(199903/04)1:2 3.0.CO;2-J
Krebsbach, P.H., Gu, K., Franceschi, R.T. and Rutherford, R.B. (2000) Gene therapy-directed osteogenesis: BMP-7transduced human fibroblasts form bone in vivo. Human Gene Therapy, 11, 1201-1210. doi:10.1089/10430340050015248
Lee, J.Y., Musgrave, D., Pelinkovic, D., Fukushima, K., Cummins, J., Usas, A., Robbins, P., Fu, F.H. and Huard, J. (2001) Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. The Journal of Bone and Joint Surgery. American Volume, 83-A, 1032-1039.
Lieberman, J.R., Le, L.Q., Wu, L., Finerman, G.A., Berk, A., Witte, O.N. and Stevenson, S. (1998) Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. Journal of Orthopaedic Research, 16, 330-339. doi:10.1002/jor.1100160309
Lou, J., Xu, F., Merkel, K. and Manske, P. (1999) Gene therapy: Adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. Journal of Orthopaedic Research, 17, 43-50. doi:10.1002/jor.1100170108
Mason, J.M., Grande, D.A., Barcia, M., Grant, R., Pergolizzi, R.G. and Breitbart, A.S. (1998) Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: Potential utility in gene therapy for osteochondral repair. Gene Therapy, 5, 1098-1104. doi:10.1038/sj.gt.3300703
Musgrave, D.S., Bosch, P., Ghivizzani, S., Robbins, P.D., Evans, C.H. and Huard, J. (1999) Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone, 24, 541-547. doi:10.1016/S8756-3282(99)00086-1
Okubo, Y., Bessho, K., Fujimura, K., Iizuka, T. and Miyatake, S.I. (2000) Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression. Biochemical and Biophysical Research Communications, 267, 382-387. doi:10.1006/bbrc.1999.1975
Oyama, M., Tatlock, A., Fukuta, S., Kavalkovich, K., Nishimura, K., Johnstone, B., Robbins, P.D., Evans, C.H. and Niyibizi, C. (1999) Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging. Gene Therapy, 6, 321-329. doi:10.1038/sj.gt.3300839
Riew, K.D., Wright, N.M., Cheng, S., Avioli, L.V. and Lou, J. (1998) Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model. Calcified Tissue International, 63, 357-360. doi:10.1007/s002239900540
Ripamonti, U., Ramoshebi, L.N., Matsaba, T., Tasker, J., Crooks, J. and Teare, J. (2001) Bone induction by BMPs/OPs and related family members in primates. The Journal of Bone and Joint Surgery. American Volume, 83-A, S116-S127.
Sandhu, H.S., Khan, S.N., Suh, D.Y. and Boden, S.D. (2001) Demineralized bone matrix, bone morphogenetic proteins, and animal models of spine fusion: An overview. European Spine Journal, 10, S122-S131. doi:10.1007/s005860100303
Varady, P., Li, J.Z., Cunningham, M., Beres, E.J., Das, S., Engh, J., Alden, T.D., Pittman, D.D., Kerns, K.M., Kallmes, D.F. and Helm, G.A. (2001) Morphologic analysis of BMP-9 gene therapy-induced osteogenesis. Human Gene Therapy, 12, 697-710. doi:10.1089/104303401300057423
Whang, K., Tsai, D.C., Nam, E.K., Aitken, M., Sprague, S.M., Patel, P.K. and Healy, K.E. (1998) Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. Journal of Biomedical Materials Research, 42, 491-499. doi:10.1002/(SICI)1097-4636(19981215)42:4 3.0.CO;2-F
He, T.C. (2005) Distinct osteogenic activity of BMPs and their orthopaedic applications. Journal of Musculoskeletal & Neuronal Interactions, 5, 363-366.
Lian, J.B., Stein, G.S., Javed, A., van Wijnen, A.J., Stein, J.L., Montecino, M., Hassan, M.Q., Gaur, T., Lengner, C.J. and Young, D.W. (2006) Networks and hubs for the transcriptional control of osteoblastogenesis. Reviews in Endocrine and Metabolic Disorders, 7, 1-16. doi:10.1007/s11154-006-9001-5
Yamaguchi, A., Komori, T. and Suda, T. (2000) Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocrine Reviews, 21, 393-411. doi:10.1210/er.21.4.393
Cheng, S.L., Lou, J., Wright, N.M., Lai, C.F., Avioli, L.V. and Riew, K.D. (2001) In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene. Calcified Tissue International, 68, 87-94. doi:10.1007/BF02678146
Partridge, K., Yang, X., Clarke, N.M., Okubo, Y., Bessho, K., Sebald, W., Howdle, S.M., Shakesheff, K.M. and Oreffo, R.O. (2002) Adenoviral BMP-2 gene transfer in mesenchymal stem cells: In vitro and in vivo bone formation on biodegradable polymer scaffolds. Biochemical and Biophysical Research Communications, 292, 144-152. doi:10.1006/bbrc.2002.6623
Yang, M., Ma, Q.J., Dang, G.T., Ma, K., Chen, P. and Zhou, C.Y. (2005) In vitro and in vivo induction of bone formation based on ex vivo gene therapy using rat adipose-derived adult stem cells expressing BMP-7. Cytotherapy, 7, 273-281. doi:10.1080/14653240510027244
Varady, P., Li, J.Z., Alden, T.D., Kallmes, D.F., Williams, M.B. and Helm, G.A. (2002) CT and radionuclide study of BMP-2 gene therapy-induced bone formation. Academic Radiology, 9, 632-637. doi:10.1016/S1076-6332(03)80307-0
Cook, S.D., Baffes, G.C., Wolfe, M.W., Sampath, T.K. and Rueger, D.C. (1994) Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clinical Orthopaedics and Related Research, 301, 302-312.
Gerhart, T.N., Kirker-Head, C.A., Kriz, M.J., Holtrop, M.E., Hennig, G.E., Hipp, J., Schelling, S.H. and Wang, E. (1993) Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clinical Orthopaedics and Related Research, 293, 317-326.
Katagiri, T., Yamaguchi, A., Ikeda, T., Yoshiki, S., Wozney, J.M., Rosen, V., Wang, E.A., Tanaka, H., Omura, S. and Suda, T. (1990) The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochemical and Biophysical Research Communications, 172, 295-299. doi:10.1016/S0006-291X(05)80208-6
Valentin-Opran, A., Wozney, J., Csimma, C., Lilly, L. and Riedel, G.E. (2002) Clinical evaluation of recombinant human bone morphogenetic protein-2. Clinical Orthopaedics and Related Research, 395, 110-120. doi:10.1097/00003086-200202000-00011
Yamaguchi, A., Katagiri, T., Ikeda, T., Wozney, J.M., Rosen, V., Wang, E.A., Kahn, A.J., Suda, T. and Yoshiki, S. (1991) Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. Journal of Cell Biology, 113, 681-687. doi:10.1083/jcb.113.3.681
Yasko, A.W., Lane, J.M., Fellinger, E.J., Rosen, V., Wozney, J.M. and Wang, E.A. (1992) The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. The Journal of Bone and Joint Surgery. American Volume, 74, 659-670.
Boden, S.D., Zdeblick, T.A., Sandhu, H.S. and Heim, S.E. (2000) The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: A preliminary report. Spine, 25, 376-381.
Govender, S., Csimma, C., Genant, H.K., Valentin-Opran, A., Amit, Y., Arbel, R., Aro, H., Atar, D., Bishay, M., Borner, M.G., Chiron, P., Choong, P., Cinats, J., Courtenay, B., Feibel, R., Geulette, B., Gravel, C., Haas, N., Raschke, M., Hammacher, E., van der Velde, D., Hardy, P., Holt, M., Josten, C., Ketterl, R.L., Lindeque, B., Lob, G., Mathevon, H., McCoy, G., Marsh, D., Miller, R., Munting, E., Oevre, S., Nordsletten, L., Patel, A., Pohl, A., Rennie, W., Reynders, P., Rommens, P.M., Rondia, J., Rossouw, W.C., Daneel, P.J., Ruff, S., Ruter, A., Santavirta, S., Schildhauer, T.A., Gekle, C., Schnettler, R., Segal, D., Seiler, H., Snowdowne, R.B., Stapert, J., Taglang, G., Verdonk, R., Vogels, L., Weckbach, A., Wentzensen, A. and Wisniewski, T. (2002) Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. The Journal of Bone and Joint Surgery. American Volume, 84-A, 2123-2134.
Bostrom, M.P. and Camacho, N.P. (1998) Potential role of bone morphogenetic proteins in fracture healing. Clinical Orthopaedics and Related Research, 355S, S274-S282.
Heckman, J.D., Boyan, B.D., Aufdemorte, T.B. and Abbott, J.T. (1991) The use of bone morphogenetic protein in the treatment of non-union in a canine model. The Journal of Bone and Joint Surgery. American Volume, 73, 750-764.
Helm, G.A., Alden, T.D., Beres, E.J., Hudson, S.B., Das, S., Engh, J.A., Pittman, D.D., Kerns, K.M. and Kallmes, D.F. (2000) Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. Journal of Neurosurgery, 92, 191-196.
Lee, A.R., Wilkins, A.C., Leather, C. and Brenton, A.G. (1994) Translational energy spectra for single-electron capture by O2+ in He, Ne, and Ar. Physical Review A, 50, 1149-1154. doi:10.1103/PhysRevA.50.1149
Luo, J., Sun, M.H., Kang, Q., Peng, Y., Jiang, W., Luu, H.H., Luo, Q., Park, J.Y., Li, Y., Haydon, R.C. and He, T.C. (2005) Gene therapy for bone regeneration. Current Gene Therapy, 5, 167-179. doi:10.2174/1566523053544218
Tang, N., Song, W.X., Luo, J., Haydon, R.C. and He, T.C. (2008) Osteosarcoma development and stem cell differrentiation. Clinical Orthopaedics and Related Research, 466, 2114-2130. doi:10.1007/s11999-008-0335-z
Wagner, E.R., He, B.C., Chen, L., Zuo, G.W., Zhang, W., Shi, Q., Luo, Q., Luo, X., Liu, B., Luo, J., Rastegar, F., He, C.J., Hu, Y., Boody, B., Luu, H.H., He, T.C., Deng, Z.L. and Haydon, R.C. (2010) Therapeutic implications of PPARgamma in human osteosarcoma. PPAR Research, 2010, 956427.
Bertone, A.L., Pittman, D.D., Bouxsein, M.L., Li, J., Clancy, B. and Seeherman, H.J. (2004) Adenoviral-mediated transfer of human BMP-6 gene accelerates healing in a rabbit ulnar osteotomy model. Journal of Orthopaedic Research, 22, 1261-1270. doi:10.1016/j.orthres.2004.03.014
Boden, S.D., Hair, G., Titus, L., Racine, M., McCuaig, K., Wozney, J.M. and Nanes, M.S. (1997) Glucocorticoidinduced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6. Endocrinology, 138, 2820-2828. doi:10.1210/en.138.7.2820
Boskey, A.L., Paschalis, E.P., Binderman, I. and Doty, S.B. (2002) BMP-6 accelerates both chondrogenesis and mineral maturation in differentiating chick limb-bud mesenchymal cell cultures. Journal of Cellular Biochemistry, 84, 509-519. doi:10.1002/jcb.10032
Ebisawa, T., Tada, K., Kitajima, I., Tojo, K., Sampath, T.K., Kawabata, M., Miyazono, K. and Imamura, T. (1999) Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. Journal of Cell Science, 112, 3519-3527.
Friedman, M.S., Long, M.W. and Hankenson, K.D. (2006) Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. Journal of Cellular Biochemistry, 98, 538-554. doi:10.1002/jcb.20719
Hughes, F.J., Collyer, J., Stanfield, M. and Goodman, S.A. (1995) The effects of bone morphogenetic protein-2,-4, and-6 on differentiation of rat osteoblast cells in vitro. Endocrinology, 136, 2671-2677. doi:10.1210/en.136.6.2671
Jane Jr., J.A., Dunford, B.A., Kron, A., Pittman, D.D., Sasaki, T., Li, J.Z., Li, H., Alden, T.D., Dayoub, H., Hankins, G.R., Kallmes, D.F. and Helm, G.A. (2002) Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer. Molecular Therapy, 6, 464-470. doi:10.1006/mthe.2002.0691
Valdes, M., Moore, D.C., Palumbo, M., Lucas, P.R., Robertson, A., Appel, J., Ehrlich, M.G. and Keeping, H.S. (2007) rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit. The Spine Journal, 7, 318-325. doi:10.1016/j.spinee.2006.02.005
Visser, R., Arrabal, P.M., Santos-Ruiz, L., Becerra, J. and Cifuentes, M. (2012) Basic fibroblast growth factor enhances the osteogenic differentiation induced by bone morphogenetic protein-6 in vitro and in vivo. Cytokine, 58, 27-33. doi:10.1016/j.cyto.2011.12.020
Yamaguchi, A., Ishizuya, T., Kintou, N., Wada, Y., Katagiri, T., Wozney, J.M., Rosen, V. and Yoshiki, S. (1996) Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochemical and Biophysical Research Communications, 220, 366-371. doi:10.1006/bbrc.1996.0411
Zachos, T.A., Shields, K.M. and Bertone, A.L. (2006) Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or-6. Journal of Orthopaedic Research, 24, 1279-1291. doi:10.1002/jor.20068
Aslan, H., Zilberman, Y., Arbeli, V., Sheyn, D., Matan, Y., Liebergall, M., Li, J.Z., Helm, G.A., Gazit, D. and Gazit, Z. (2006) Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Engineering, 12, 877-889. doi:10.1089/ten.2006.12.877
Santos, J.L., Pandita, D., Rodrigues, J., Pego, A.P., Granja, P.L. and Tomas, H. (2011) Non-viral gene delivery to mesenchymal stem cells: Methods, strategies and application in bone tissue engineering and regeneration. Current Gene Therapy, 11, 46-57. doi:10.2174/156652311794520102
Sheyn, D., Kimelman-Bleich, N., Pelled, G., Zilberman, Y., Gazit, D. and Gazit, Z. (2008) Ultrasound-based nonviral gene delivery induces bone formation in vivo. Gene Therapy, 15, 257-266. doi:10.1038/sj.gt.3303070
Bergeron, E., Senta, H., Mailloux, A., Park, H., Lord, E. and Faucheux, N. (2009) Murine preosteoblast differenttiation induced by a peptide derived from bone morphogenetic proteins-9. Tissue Engineering Part A, 15, 3341-3349. doi:10.1089/ten.tea.2009.0189
Lee, J.Y., Peng, H., Usas, A., Musgrave, D., Cummins, J., Pelinkovic, D., Jankowski, R., Ziran, B., Robbins, P. and Huard, J. (2002) Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. Human Gene Therapy, 13, 1201-1211. doi:10.1089/104303402320138989
Dumont, R.J., Dayoub, H., Li, J.Z., Dumont, A.S., Kallmes, D.F., Hankins, G.R. and Helm, G.A. (2002) Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents. Neurosurgery, 51, 1239-1244.
Kimelman-Bleich, N., Pelled, G., Zilberman, Y., Kallai, I., Mizrahi, O., Tawackoli, W., Gazit, Z. and Gazit, D. (2011) Targeted gene-and-host progenitor cell therapy for nonunion bone fracture repair. Molecular Therapy, 19, 53-59. doi:10.1038/mt.2010.190
Li, X., Chen. L., Ke, Z.-Y., Yin, L.-J. and Deng, Z.-L. (2012) BMP9-induced osteogenic differentiation and bone formation of muscle-derived stem cells. Journal of Biomedicine and Biotechnology, 2012, 1.
Brown, M.A., Zhao, Q., Baker, K.A., Naik, C., Chen, C., Pukac, L., Singh, M., Tsareva, T., Parice, Y., Mahoney, A., Roschke, V., Sanyal, I. and Choe, S. (2005) Crystal structure of BMP-9 and functional interactions with pro-region and receptors. The Journal of Biological Chemistry, 280, 25111-25118. doi:10.1074/jbc.M503328200
Canalis, E., Economides, A.N. and Gazzerro, E. (2003) Bone morphogenetic proteins, their antagonists, and the skeleton. Endocrine Reviews, 24, 218-235. doi:10.1210/er.2002-0023
Hill, J.J., Qiu, Y., Hewick, R.M. and Wolfman, N.M. (2003) Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: A novel protein with protease inhibitor and follistatin domains. Molecular Endocrinology, 17, 1144-1154. doi:10.1210/me.2002-0366
Li, J.Z., Li, H., Sasaki, T., Holman, D., Beres, B., Dumont, R.J., Pittman, D.D., Hankins, G.R. and Helm, G.A. (2003) Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Therapy, 10, 1735-1743. doi:10.1038/sj.gt.3302075
Sieber, C., Kopf, J., Hiepen, C. and Knaus, P. (2009) Recent advances in BMP receptor signaling. Cytokine & Growth Factor Reviews, 20, 343-355. doi:10.1016/j.cytogfr.2009.10.007
Zhou, L., An, N., Jiang, W., Haydon, R., Cheng, H., Zhou, Q., Breyer, B., Feng, T. and He, T.C. (2002) Fluorescence-based functional assay for Wnt/beta-catenin signaling activity. Biotechniques, 33, 1126-1128, 1130, 1132 passim.
Massague, J. (1998) TGF-beta signal transduction. Annual Review of Biochemistry, 67, 753-791. doi:10.1146/annurev.biochem.67.1.753
Yamashita, H., Ten Dijke, P., Heldin, C.H. and Miyazono, K. (1996) Bone morphogenetic protein receptors. Bone, 19, 569-574. doi:10.1016/S8756-3282(96)00259-1
Yamashita, H. and Miyazono, K. (1999) Bone morphogenetic protein (BMP) receptors and signal transduction. Nihon Rinsho, 57, 220-226.
Scharpfenecker, M., van Dinther, M., Liu, Z., van Bezooijen, R.L., Zhao, Q., Pukac, L., Lowik, C.W. and ten Dijke, P. (2007) BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. Journal of Cell Science, 120, 964-972. doi:10.1242/jcs.002949
Shao, E.S., Lin, L., Yao, Y. and Bostrom, K.I. (2009) Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells. Blood, 114, 2197-2206. doi:10.1182/blood-2009-01-199166
Upton, P.D., Davies, R.J., Trembath, R.C. and Morrell, N.W. (2009) Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells. The Journal of Biological Chemistry, 284, 15794-15804. doi:10.1074/jbc.M109.002881
Massague, J., Seoane, J. and Wotton, D. (2005) Smad transcription factors. Genes & Development, 19, 2783-2810. doi:10.1101/gad.1350705
Nohe, A., Keating, E., Knaus, P. and Petersen, N.O. (2004) Signal transduction of bone morphogenetic protein receptors. Cellular Signalling, 16, 291-299. doi:10.1016/j.cellsig.2003.08.011
Heldin, C.H., Miyazono, K. and ten Dijke, P. (1997) TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature, 390, 465-471.
Derynck, R., Zhang, Y. and Feng, X.H. (1998) Smads: transcriptional activators of TGF-beta responses. Cell, 95, 737-740. doi:10.1016/S0092-8674(00)81696-7
Itoh, S., Itoh, F., Goumans, M.J. and Ten Dijke, P. (2000) Signaling of transforming growth factor-beta family members through Smad proteins. European Journal of Biochemistry, 267, 6954-6967. doi:10.1046/j.1432-1327.2000.01828.x
Miyazono, K., ten Dijke, P. and Heldin, C.H. (2000) TGF-beta signaling by Smad proteins. Advances in Immunology, 75, 115-157. doi:10.1016/S0065-2776(00)75003-6
Ten Dijke, P., Goumans, M.J., Itoh, F. and Itoh, S. (2002) Regulation of cell proliferation by Smad proteins. Journal of Cellular Physiology, 191, 1-16. doi:10.1002/jcp.10066
Miyazono, K., Maeda, S. and Imamura, T. (2005) BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine & Growth Factor Reviews, 16, 251-263. doi:10.1016/j.cytogfr.2005.01.009
Xu, D.J., Zhao, Y.-Z., Wang, J., He, J.W., Weng, Y.G. and Luo, J.Y. (2011) Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. BMB Reports, 45, 247-252.
Kreider, B.L., Benezra, R., Rovera, G. and Kadesch, T. (1992) Inhibition of myeloid differentiation by the helixloop-helix protein Id. Science, 255, 1700-1702. doi:10.1126/science.1372755
Norton, J.D. (2000) ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. Journal of Cell Science, 113, 3897-3905.
Ruzinova, M.B. and Benezra, R. (2003) Id proteins in development, cell cycle and cancer. Trends in Cell Biology, 13, 410-418. doi:10.1016/S0962-8924(03)00147-8
Blom, I.E., Goldschmeding, R. and Leask, A. (2002) Gene regulation of connective tissue growth factor: New targets for antifibrotic therapy? Matrix Biology, 21, 473-482. doi:10.1016/S0945-053X(02)00055-0
Brigstock, D.R. (2003) The CCN family: A new stimulus package. Journal of Endocrinology, 178, 169-175. doi:10.1677/joe.0.1780169
Brigstock, D.R., Goldschmeding, R., Katsube, K.I., Lam, S.C., Lau, L.F., Lyons, K., Naus, C., Perbal, B., Riser, B., Takigawa, M. and Yeger, H. (2003) Proposal for a unified CCN nomenclature. Molecular Pathology, 56, 127-128. doi:10.1136/mp.56.2.127
Lau, L.F. and Lam, S.C. (1999) The CCN family of angiogenic regulators: The integrin connection. Experimental Cell Research, 248, 44-57. doi:10.1006/excr.1999.4456
Moussad, E.E. and Brigstock, D.R. (2000) Connective tissue growth factor: What’s in a name? Molecular Genetics and Metabolism, 71, 276-292. doi:10.1006/mgme.2000.3059
Planque, N. and Perbal, B. (2003) A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis. Cancer Cell International, 3, 15. doi:10.1186/1475-2867-3-15
Ivkovic, S., Yoon, B.S., Popoff, S.N., Safadi, F.F., Libuda, D.E., Stephenson, R.C., Daluiski, A. and Lyons, K.M. (2003) Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development and Disease, 130, 2779-2791. doi:10.1242/dev.00505
Sharff, K.A., Song, W.X., Luo, X., Tang, N., Luo, J., Chen, J., Bi, Y., He, B.C., Huang, J., Li, X., Jiang, W., Zhu, G.H., Su, Y., He, Y., Shen, J., Wang, Y., Chen, L., Zuo, G.W., Liu, B., Pan, X., Reid, R.R., Luu, H.H., Haydon, R.C. and He, T.C. (2009) Hey1 basic helix-loop-helix protein plays an important role in mediating BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. The Journal of Biological Chemistry, 284, 649-659. doi:10.1074/jbc.M806389200
Massague, J. and Chen, Y.G. (2000) Controlling TGF-beta signaling. Genes & Development, 14, 627-644.
Massague, J. and Wotton, D. (2000) Transcriptional control by the TGF-beta/Smad signaling system. The EMBO Journal, 19, 1745-1754. doi:10.1093/emboj/19.8.1745
Siegel, P.M. and Massague, J. (2003) Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nature Reviews. Cancer, 3, 807-821.
Siegel, P.M., Shu, W., Cardiff, R.D., Muller, W.J. and Massague, J. (2003) Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proceedings of the National Academy of Sciences of the United States of America, 100, 8430-8435. doi:10.1073/pnas.0932636100
Alliston, T., Choy, L., Ducy, P., Karsenty, G. and Derynck, R. (2001) TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. The EMBO Journal, 20, 2254-2272. doi:10.1093/emboj/20.9.2254
Li, R.D., Deng, Z.L., Hu, N., Liang, X., Liu, B., Luo, J., Chen, L., Yin, L., Luo, X., Shui, W., He, T.C. and Huang, W. (2012) Biphasic effects of TGFbeta1 on BMP9-induced osteogenic differentiation of mesenchymal stem cells. BMB Reports, 45, 509-514.
Maeda, S., Hayashi, M., Komiya, S., Imamura, T. and Miyazono, K. (2004) Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. The EMBO Journal, 23, 552-563. doi:10.1038/sj.emboj.7600067
Huang, E., Zhu, G., Jiang, W., Yang, K., Gao, Y., Luo, Q., Gao, J.L., Kim, S.H., Liu, X., Li, M., Shi, Q., Hu, N., Wang, L., Liu, H., Cui, J., Zhang, W., Li, R., Chen, X., Kong, Y.H., Zhang, J., Wang, J., Shen, J., Bi, Y., Statz, J., He, B.C., Luo, J., Wang, H., Xiong, F., Luu, H.H., Haydon, R.C., Yang, L. and He, T.C. (2012) Growth hormone synergizes with BMP9 in osteogenic differentiation by activating the JAK/STAT/IGF1 pathway in murine multilineage cells. Journal of Bone and Mineral Research, 27, 1566-1575. doi:10.1002/jbmr.1622
Blair, J.C. and Savage, M.O. (2002) The GH-IGF-I axis in children with idiopathic short stature. Trends in Endocrinology & Metabolism, 13, 325-330. doi:10.1016/S1043-2760(02)00631-8
Brooks, A.J. and Waters, M.J. (2010) The growth hormone receptor: Mechanism of activation and clinical implications. Nature Reviews. Endocrinology, 6, 515-525.
Hull, K.L. and Harvey, S. (2000) Growth hormone: Roles in male reproduction. Endocrine, 13, 243-250. doi:10.1385/ENDO:13:3:243
Hull, K.L. and Harvey, S. (2000) Growth hormone: A reproductive endocrine-paracrine regulator? Reviews of Reproduction, 5, 175-182. doi:10.1530/ror.0.0050175
Park, P. and Cohen, P. (2005) Insulin-like growth factor I (IGF-I) measurements in growth hormone (GH) therapy of idiopathic short stature (ISS). Growth Hormone & IGF Research, 15, S13-S20.
Tanaka, H. (1998) Growth hormone and bone diseases. Endocrine Journal, 45, S47-S52. doi:10.1507/endocrj.45.Suppl_S47
Thomas, M.J. (1998) The molecular basis of growth hormone action. Growth Hormone & IGF Research, 8, 3-11. doi:10.1016/S1096-6374(98)80316-X
Randhawa, R. and Cohen, P. (2005) The role of the insulin-like growth factor system in prenatal growth. Molecular Genetics and Metabolism, 86, 84-90. doi:10.1016/j.ymgme.2005.07.028
O’Dell, S.D. and Day, I.N. (1998) Insulin-like growth factor II (IGF-II). The International Journal of Biochemistry & Cell Biology, 30, 767-771. doi:10.1016/S1357-2725(98)00048-X
Bergwitz, C., Wendlandt, T., Kispert, A. and Brabant, G. (2001) Wnts differentially regulate colony growth and differentiation of chondrogenic rat calvaria cells. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1538, 129-140. doi:10.1016/S0167-4889(00)00123-3
Cadigan, K.M. and Nusse, R. (1997) Wnt signaling: A common theme in animal development. Genes & Development, 11, 3286-3305. doi:10.1101/gad.11.24.3286
Fischer, L., Boland, G. and Tuan, R.S. (2002) Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis. Journal of Cellular Physiology, 84, 816-831. doi:10.1002/jcb.10091
Glass 2nd., D.A. and Karsenty, G. (2006) Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway. Current Topics in Developmental Biology, 73, 43-84. doi:10.1016/S0070-2153(05)73002-7
Glass 2nd., D.A. and Karsenty, G. (2007) In vivo analysis of Wnt signaling in bone. Endocrinology, 148, 2630-2634. doi:10.1210/en.2006-1372
Karsenty, G. and Wagner, E.F. (2002) Reaching a genetic and molecular understanding of skeletal development. Developmental Cell, 2, 389-406. doi:10.1016/S1534-5807(02)00157-0
Wang, J. and Wynshaw-Boris, A. (2004) The canonical Wnt pathway in early mammalian embryogenesis and stem cell maintenance/differentiation. Current Opinion in Genetics & Development, 14, 533-539. doi:10.1016/j.gde.2004.07.013
Tang, N., Song, W.X., Luo, J., Luo, X., Chen, J., Sharff, K.A., Bi, Y., He, B.C., Huang, J.Y., Zhu, G.H., Su, Y.X., Jiang, W., Tang, M., He, Y., Wang, Y., Chen, L., Zuo, G.W., Shen, J., Pan, X., Reid, R.R., Luu, H.H., Haydon, R.C. and He, T.C. (2009) BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling. Journal of Cellular and Molecular Medicine, 13, 2448-2464. doi:10.1111/j.1582-4934.2008.00569.x
Gong, Y., Slee, R.B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A.M., Wang, H., Cundy, T., Glorieux, F.H., Lev, D., Zacharin, M., Oexle, K., Marcelino, J., Suwairi, W., Heeger, S., Sabatakos, G., Apte, S., Adkins, W.N., Allgrove, J., Arslan-Kirchner, M., Batch, J.A., Beighton, P., Black, G.C., Boles, R.G., Boon, L.M., Borrone, C., Brunner, H.G., Carle, G.F., Dallapiccola, B., De Paepe, A., Floege, B., Halfhide, M.L., Hall, B., Hennekam, R.C., Hirose, T., Jans, A., Juppner, H., Kim, C.A., Keppler-Noreuil, K., Kohlschuetter, A., LaCombe, D., Lambert, M., Lemyre, E., Letteboer, T., Peltonen, L., Ramesar, R.S., Romanengo, M., Somer, H., Steichen-Gersdorf, E., Steinmann, B., Sullivan, B., Superti-Furga, A., Swoboda, W., van den Boogaard, M.J., Van Hul, W., Vikkula, M., Votruba, M., Zabel, B., Garcia, T., Baron, R., Olsen, B.R. and Warman, M.L. (2001) LDL receptorrelated protein 5 (LRP5) affects bone accrual and eye development. Cell, 107, 513-523. doi:10.1016/S0092-8674(01)00571-2
Celil, A.B. and Campbell, P.G. (2005) BMP-2 and insulin-like growth factor-I mediate osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. The Journal of Biological Chemistry, 280, 31353-31359. doi:10.1074/jbc.M503845200
Chang, S.F., Chang, T.K., Peng, H.H., Yeh, Y.T., Lee, D.Y., Yeh, C.R., Zhou, J., Cheng, C.K., Chang, C.A. and Chiu, J.J. (2009) BMP-4 induction of arrest and differenttiation of osteoblast-like cells via p21CIP1 and p27KIP1 regulation. Molecular Endocrinology, 23, 1827-1838. doi:10.1210/me.2009-0143
Gallea, S., Lallemand, F., Atfi, A., Rawadi, G., Ramez, V., Spinella-Jaegle, S., Kawai, S., Faucheu, C., Huet, L., Baron, R. and Roman-Roman, S. (2001) Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone, 28, 491-498. doi:10.1016/S8756-3282(01)00415-X
Noth, U., Tuli, R., Seghatoleslami, R., Howard, M., Shah, A., Hall, D.J., Hickok, N.J. and Tuan, R.S. (2003) Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Experimental Cell Research, 291, 201-211. doi:10.1016/S0014-4827(03)00386-0
Miyazono, K., Kamiya, Y. and Morikawa, M. (2010) Bone morphogenetic protein receptors and signal transduction. The Journal of Biochemistry, 147, 35-51. doi:10.1093/jb/mvp148
Verheyen, E.M. (2007) Opposing effects of Wnt and MAPK on BMP/Smad signal duration. Developmental Cell, 13, 755-756. doi:10.1016/j.devcel.2007.11.006
Majmundar, A.J., Wong, W.J. and Simon, M.C. (2010) Hypoxia-inducible factors and the response to hypoxic stress. Molecular Cell, 40, 294-309. doi:10.1016/j.molcel.2010.09.022
Giaginis, C., Tsantili-Kakoulidou, A. and Theocharis, S. (2007) Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism. Fundamental & Clinical Pharmacology, 21, 231-244. doi:10.1111/j.1472-8206.2007.00486.x
Muruganandan, S., Roman, A.A. and Sinal, C.J. (2009) Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: Cross talk with the osteoblastogenic program. Cellular and Molecular Life Sciences, 66, 236-253. doi:10.1007/s00018-008-8429-z
Chawla, A., Repa, J.J., Evans, R.M. and Mangelsdorf, D.J. (2001) Nuclear receptors and lipid physiology: Opening the X-files. Science, 294, 1866-1870. doi:10.1126/science.294.5548.1866
Mark, M., Ghyselinck, N.B. and Chambon, P. (2006) Function of retinoid nuclear receptors: Lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annual Review of Pharmacology and Toxicology, 46, 451-480. doi:10.1146/annurev.pharmtox.46.120604.141156
Chen, L., Jiang, W., Huang, J., He, B.C., Zuo, G.W., Zhang, W., Luo, Q., Shi, Q., Zhang, B.Q., Wagner, E.R., Luo, J., Tang, M., Wietholt, C., Luo, X., Bi, Y., Su, Y., Liu, B., Kim, S.H., He, C.J., Hu, Y., Shen, J., Rastegar, F., Huang, E., Gao, Y., Gao, J.L., Zhou, J.Z., Reid, R.R., Luu, H.H., Haydon, R.C., He, T.C. and Deng, Z.L. (2010) Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. Journal of Bone and Mineral Research, 25, 2447-2459. doi:10.1002/jbmr.133
Zhao, Y., Song, T., Wang, W., Wang, J., He, J., Wu, N., Tang, M., He, B. and Luo, J. (2012) P38 and ERK1/2 MAPKs act in opposition to regulate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One, 7, e43383. doi:10.1371/journal.pone.0043383
Hu, N., Jiang, D., Huang, E., Liu X., Li, R.D., Liang, X., Stephanie, H. and Kim, X.C., Gao, J.-L., Zhang, H.Y. and Zhang, W.W. (2013) BMP9-regulated angiogenic signaling plays an important role in the osteogenic differentiation of mesenchymal progenitor cells. Journal of Cell Science, 126, 532-541.
Zhang, W., Deng, Z.L., Chen, L., Zuo, G.W., Luo, Q., Shi, Q., Zhang, B.Q., Wagner, E.R., Rastegar, F., Kim, S.H., Jiang, W., Shen, J., Huang, E., Gao, Y., Gao, J.L., Zhou, J.Z., Luo, J., Huang, J., Luo, X., Bi, Y., Su, Y., Yang, K., Liu, H., Luu, H.H., Haydon, R.C., He, T.C. and He, B.C. (2010) Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One, 5, e11917. doi:10.1371/journal.pone.0011917
Castonguay, R., Werner, E.D., Matthews, R.G., Presman, E., Mulivor, A.W., Solban, N., Sako, D., Pearsall, R.S, Underwood, K.W., Seehra, J., Kumar, R. and Grinberg, A.V. (2011) Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. The Journal of Biological Chemistry, 286, 30034-30046. doi:10.1074/jbc.M111.260133
Li, B., Yang, Y., Jiang, S., Ni, B., Chen, K. and Jiang, L. (2012) Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway. Internation Journal of Oncology, 41, 1809-1819.
Ye, L., Kynaston, H. and Jiang, W.G. (2008) Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4. Molecular Cancer Research, 6, 1594-1606. doi:10.1158/1541-7786.MCR-08-0171
van Meeteren, L.A., Thorikay, M., Bergqvist, S., Pardali, E., Stampino, C.G., Hu-Lowe, D., Goumans, M.J. and ten Dijke, P. (2012) Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting. The Journal of Biological Chemistry, 287, 18551-18561. doi:10.1074/jbc.M111.338103
Ricard, N., Ciais, D., Levet, S., Subileau, M., Mallet, C., Zimmers, T.A., Lee, S.J., Bidart, M., Feige, J.J. and Bailly, S. (2012) BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. Blood, 119, 6162-6171. doi:10.1182/blood-2012-01-407593
Suzuki, Y., Ohga, N., Morishita, Y., Hida, K., Miyazono, K. and Watabe, T. (2010) BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo. Journal of Cell Science, 123, 1684-1692. doi:10.1242/jcs.061556
David, L., Mallet, C., Keramidas, M., Lamande, N., Gasc, J.M., Dupuis-Girod, S., Plauchu, H., Feige, J.J. and Bailly, S. (2008) Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circulation Research, 102, 914-922. doi:10.1161/CIRCRESAHA.107.165530
Park, J.E., Shao, D., Upton, P.D., Desouza, P., Adcock, I.M., Davies, R.J., Morrell, N.W., Griffiths, M.J. and Wort, S.J. (2012) BMP-9 induced endothelial cell tubule formation and inhibition of migration involves Smad1 driven endothelin-1 production. PLoS One, 7, e30075. doi:10.1371/journal.pone.0030075
Yao, Y., Jumabay, M., Ly, A., Radparvar, M., Wang, A.H., Abdmaulen, R. and Bostrom, K.I. (2012) Crossveinless 2 regulates bone morphogenetic protein 9 in human and mouse vascular endothelium. Blood, 119, 5037-5047. doi:10.1182/blood-2011-10-385906
Lopez-Coviella, I., Follettie, M.T., Mellott, T.J., Kovacheva, V.P., Slack, B.E., Diesl, V., Berse, B., Thies, R.S. and Blusztajn, J.K. (2005) Bone morphogenetic protein 9 induces the transcriptome of basal forebrain cholinergic neurons. Proceedings of the National Academy of Sciences of the United States of America, 102, 6984-6989. doi:10.1073/pnas.0502097102
Lopez-Coviella, I., Mellott, T.J., Schnitzler, A.C. and Blusztajn, J.K. (2011) BMP9 protects septal neurons from axotomy-evoked loss of cholinergic phenotype. PLoS One, 6, e21166. doi:10.1371/journal.pone.0021166
Schnitzler, A.C., Lopez-Coviella, I. and Blusztajn, J.K. (2008) Differential modulation of nerve growth factor receptor (p75) and cholinergic gene expression in purified p75-expressing and non-expressing basal forebrain neurons by BMP9. Brain Research, 1246, 19-28. doi:10.1016/j.brainres.2008.09.085
Schnitzler, A.C., Mellott, T.J., Lopez-Coviella, I., Tallini, Y.N., Kotlikoff, M.I., Follettie, M.T. and Blusztajn, J.K. (2010) BMP9 (bone morphogenetic protein 9) induces NGF as an autocrine/paracrine cholinergic trophic factor in developing basal forebrain neurons. Journal of Neuroscience, 30, 8221-8228. doi:10.1523/JNEUROSCI.5611-09.2010
Caperuto, L.C., Anhe, G.F., Cambiaghi, T.D., Akamine, E.H., do Carmo Buonfiglio, D., Cipolla-Neto, J., Curi, R. and Bordin, S. (2008) Modulation of bone morphogenetic protein-9 expression and processing by insulin, glucose, and glucocorticoids: Possible candidate for hepatic insulin-sensitizing substance. Endocrinology, 149, 6326-6335. doi:10.1210/en.2008-0655
Sosa, I., Cvijanovic, O., Celic, T., Cuculic, D., CrncevicOrlic, Z., Vukelic, L., Zoricic Cvek, S., Dudaric, L., Bosnar, A. and Bobinac, D. (2011) Hepatoregenerative role of bone morphogenetic protein-9. Medical Science Monitor, 17, 33-35. doi:10.12659/MSM.882108
Blunk, T., Sieminski, A.L., Appel, B., Croft, C., Courter, D.L., Chieh, J.J., Goepferich, A., Khurana, J.S. and Gooch, K.J. (2003) Bone morphogenetic protein 9: A potent modulator of cartilage development in vitro. Growth Factors, 21, 71-77. doi:10.1080/0897719031000148822
Majumdar, M.K., Wang, E. and Morris, E.A. (2001) BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. Journal of Cellular Physiology, 189, 275-284. doi:10.1002/jcp.10025